Envíos recientes

Lurbinectedin Plus Pembrolizumab in Relapsed SCLC: The Phase I/II LUPER Study

Calles, Antonio; Doger de Speville Uribe, Bernard Gaston; Álvarez Colomé, Enric; de Miguel, María; NAVARRO, ALEJANDRO; ALVAREZ, ROSA; Rocha, Pedro; FELIP, ENRIQUETA (Elsevier, 2025-07)

Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemia

Hutchings, Martin; Korfi, Koorosh; HOU, HSIN-AN; Martínez-Sanchez, Pilar; Montesinos, Pau; Santoro, Armando; Salamero, Olga (Elsevier, 2025-08)

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

Shitara, Kohei; Lorenzen, Sylvie; Li, Jin; Bai, Yuxian; González Fernández, Manuel; Aguilar, Mynor; Acosta Eyzaguirre, Daniel; Tabernero, Josep (American Society of Clinical Oncology, 2025-08-01)

Best practices in sample management and molecular profiling of cholangiocarcinoma: a practical guide

Castet, Florian; Salcedo, Maria-Teresa; Nuciforo, Paolo; Aguilar, Susana; Vivancos, Ana (Taylor & Francis, 2025)

Biliary tract cancers: addressing healthcare disparities and improving access to innovative treatments in Europe

Boilève, Alice; Neuzillet, Cindy; Turpin, Anthony; TIAN, TIAN (Elsevier, 2025-03)

Scientia. Depósito de Información Digital del Departamento de Salud

VHIO - Articles científics: Envíos recientes

Lurbinectedin Plus Pembrolizumab in Relapsed SCLC: The Phase I/II LUPER Study

Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemia

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

Best practices in sample management and molecular profiling of cholangiocarcinoma: a practical guide

Biliary tract cancers: addressing healthcare disparities and improving access to innovative treatments in Europe

Scientia. Depósito de Información Digital del Departamento de Salud

VHIO - Articles científics: Envíos recientes

Lurbinectedin Plus Pembrolizumab in Relapsed SCLC: The Phase I/II LUPER Study ﻿

Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemia ﻿

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study ﻿

Best practices in sample management and molecular profiling of cholangiocarcinoma: a practical guide ﻿

Biliary tract cancers: addressing healthcare disparities and improving access to innovative treatments in Europe ﻿

Lurbinectedin Plus Pembrolizumab in Relapsed SCLC: The Phase I/II LUPER Study

Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemia

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

Best practices in sample management and molecular profiling of cholangiocarcinoma: a practical guide

Biliary tract cancers: addressing healthcare disparities and improving access to innovative treatments in Europe